Early symptom change prediction of remission in depression treatment

Psychopharmacology Bulletin

Volumn 42, Issue 1, 2009, Pages 94-107

  Katz, Martin M ^a   Meyers, Adam L ^b   Prakash, Apurva ^b   Gaynor, Paula J ^b   Houston, John P ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Antidepressant; Duloxetine; Escitalopram; Onset of action; Predictors of remission

Indexed keywords

DULOXETINE; ESCITALOPRAM; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MOTOR ACTIVITY; MOTOR RETARDATION; PREDICTION; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; SUICIDAL BEHAVIOR; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; THIOPHENES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349127301     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)